These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23251632)

  • 21. Ustekinumab: moving the target from psoriasis to Crohn's disease.
    Settesoldi A; Coppola M; Rogai F; Annese V
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):5-13. PubMed ID: 24410468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed results with modulation of TH-17 cells in human autoimmune diseases.
    Steinman L
    Nat Immunol; 2010 Jan; 11(1):41-4. PubMed ID: 20016509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of co-stimulation in the orchestration of T helper cell differentiation.
    Coquet JM; Rausch L; Borst J
    Immunol Cell Biol; 2015 Oct; 93(9):780-8. PubMed ID: 25801480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.
    Tahvili S; Zandieh B; Amirghofran Z
    Int J Dermatol; 2015 Jul; 54(7):e254-60. PubMed ID: 26108267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells.
    Staeva-Vieira TP; Freedman LP
    J Immunol; 2002 Feb; 168(3):1181-9. PubMed ID: 11801653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
    Toussirot E; Michel F; Béreau M; Binda D
    Patient Prefer Adherence; 2013; 7():369-77. PubMed ID: 23641151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germinal centers regulate human Th2 development.
    Johansson-Lindbom B; Ingvarsson S; Borrebaeck CA
    J Immunol; 2003 Aug; 171(4):1657-66. PubMed ID: 12902463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotransmitter signalling via NMDA receptors leads to decreased T helper type 1-like and enhanced T helper type 2-like immune balance in humans.
    Orihara K; Odemuyiwa SO; Stefura WP; Ilarraza R; HayGlass KT; Moqbel R
    Immunology; 2018 Mar; 153(3):368-379. PubMed ID: 28940416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ustekinumab.
    Weber J; Keam SJ
    BioDrugs; 2009; 23(1):53-61. PubMed ID: 19344192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.
    Tsai TF; Ho V; Song M; Szapary P; Kato T; Wasfi Y; Li S; Shen YK; Leonardi C;
    Br J Dermatol; 2012 Nov; 167(5):1145-52. PubMed ID: 22803615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells.
    Orgun NN; Mathis MA; Wilson CB; Way SS
    J Immunol; 2008 Mar; 180(6):4109-15. PubMed ID: 18322221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis.
    Koutruba N; Emer J; Lebwohl M
    Ther Clin Risk Manag; 2010 Apr; 6():123-41. PubMed ID: 20421912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.
    Brodmerkel C; Wadman E; Langley RG; Papp KA; Bourcier M; Poulin Y; Ho V; Guenther L; Kunynetz R; Nigen S; Vender R; Wasel N; Hsu MC; Szapary P
    J Drugs Dermatol; 2013 Oct; 12(10):1122-9. PubMed ID: 24085047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ustekinumab associated with flares of psoriatic arthritis.
    Stamell EF; Kutner A; Viola K; Cohen SR
    JAMA Dermatol; 2013 Dec; 149(12):1410-3. PubMed ID: 24132520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab.
    Gedebjerg A; Johansen C; Kragballe K; Iversen L
    Acta Derm Venereol; 2013 Mar; 93(2):150-5. PubMed ID: 22930279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab.
    Campbell K; Li K; Yang F; Branigan P; Elloso MM; Benson J; Orlovsky Y; Chen Y; Garcet S; Krueger JG
    Immunohorizons; 2023 Apr; 7(4):273-285. PubMed ID: 37071038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review of interleukin-12, interleukin-17, and interleukin-23 pathway inhibitors for the treatment of moderate-to-severe chronic plaque psoriasis: ustekinumab, briakinumab, tildrakizumab, guselkumab, secukinumab, ixekizumab, and brodalumab.
    Tausend W; Downing C; Tyring S
    J Cutan Med Surg; 2014; 18(3):156-69. PubMed ID: 24800703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.